Twist Bioscience Corporation
Twist Bioscience Corporation（TWST）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · TWST · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
127
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Twist Bioscience Corporation内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
TWST 季度内部人买卖趋势
TWST 内幕交易卖出 · TWST 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · TWST CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
TWST 高管卖出股份 · TWST 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 29, 2026 | Cho Dennis See Remarks | Sale | 14,205 | $991K | Form 4 |
| May 29, 2026 | Laponis Adam CFO | Sale | 4,000 | $280K | Form 4 |
| May 28, 2026 | Leproust Emily M. CEO · Director | Option | 16,470 | $145K | Form 4 |
| May 28, 2026 | Leproust Emily M. CEO · Director | Sale | 1,482 | $97K | Form 4 |
| May 28, 2026 | Leproust Emily M. CEO · Director | Sale | 900 | $60K | Form 4 |
| May 28, 2026 | Leproust Emily M. CEO · Director | Sale | 7,623 | $518K | Form 4 |
| May 28, 2026 | Leproust Emily M. CEO · Director | Sale | 6,465 | $444K | Form 4 |
| May 28, 2026 | Starovasnik Melissa A. Director | Sale | 2,500 | $170K | Form 4 |
| May 26, 2026 | Starovasnik Melissa A. Director | Sale | 500 | $31K | Form 4 |
| May 27, 2026 | Leproust Emily M. CEO · Director | Option | 25,017 | $221K | Form 4 |
| May 26, 2026 | Leproust Emily M. CEO · Director | Option | 24,282 | $214K | Form 4 |
| May 27, 2026 | Leproust Emily M. CEO · Director | Sale | 23,752 | $1.55M⚡ | Form 4 |
| May 26, 2026 | Leproust Emily M. CEO · Director | Sale | 24,282 | $1.58M⚡ | Form 4 |
| May 27, 2026 | Leproust Emily M. CEO · Director | Sale | 1,265 | $84K | Form 4 |
| May 26, 2026 | WERNER ROBERT F. CAO | Sale | 800 | $50K | Form 4 |
| May 21, 2026 | Green Paula SVP of Human Resources | Sale | 1,399 | $75K | Form 4 |
| May 21, 2026 | Finn Patrick John President and COO | Sale | 4,160 | $222K | Form 4 |
| May 21, 2026 | Cho Dennis See Remarks | Sale | 1,642 | $87K | Form 4 |
| May 21, 2026 | WERNER ROBERT F. CAO | Sale | 688 | $37K | Form 4 |
| May 21, 2026 | Leproust Emily M. CEO · Director | Sale | 6,888 | $367K | Form 4 |
| May 21, 2026 | Laponis Adam CFO | Sale | 2,019 | $108K | Form 4 |
| May 12, 2026 | JOHANNESSEN JAN Director | Option | 12,000 | $168K | Form 4 |
| May 12, 2026 | JOHANNESSEN JAN Director | Sale | 12,000 | $673K | Form 4 |
| May 8, 2026 | WERNER ROBERT F. CAO | Sale | 4,961 | $282K | Form 4 |
| May 4, 2026 | Cho Dennis See Remarks | Sale | 1,962 | $112K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 TWST 内幕交易
TWST 内幕交易
Twist Bioscience Corporation（TWST）内幕交易数据来源于公司内部人（包括Leproust Emily M. (CEO · Director), Finn Patrick John (President and COO), WERNER ROBERT F. (CAO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。TWST内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Twist Bioscience Corporation机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
TWST 内幕交易 · 5个问题Twist Bioscience Corporation（TWST）的内部人包括高管和董事，如Leproust Emily M. (CEO · Director), Finn Patrick John (President and COO), WERNER ROBERT F. (CAO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026